A prospective, open label clinical trial to evaluate the efficacy and safety of Tubby nutririch lotion for the treatment of dry skin with or without Atopic tendency in infants and children.

Sante Mernaud Pharmaceuticals Pvt Ltd0 sites15 target enrollmentTBD

Overview

No summary available.

Registry

who.int

Start Date

TBD

End Date

December 26, 2012

Last Updated

4 years ago

Study Type

Interventional

Sponsor

Sante Mernaud Pharmaceuticals Pvt Ltd

•Patient has clinically infected atopic dermatitis at baseline.
•Patient with known hypersensitivity in general, to study drug or any excipients of the product
•Any dermatological condition other than atopic dermatitis that in the Investigators opinion may interfere with the evaluation of the patients atopic dermatitis
•Patients using non\-sedating histamines least 7 days prior to the first dosing day or throughout the study.
•Severe Atopic Dermatitis
•History of other skin disorders, that could interfere with the evaluations
•Use of any topical treatment known or suspected to have an effect on atopic dermatitis within one week prior to the screen visit (except for calcineurin inhibitors, for which the washout is 2 weeks)
•Patients with severe medical condition(s) that in the view of the investigator prohibits participation in the study
•Use of any other investigational agent in the last 30 days